Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study by Jossy van den Boogaard, Ramsey A Lyimo, Martin J Boeree, Gibson S Kibiki, Rob E Aarnoutse

Get full text

High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistance. by Antal Martinecz, Martin J Boeree, Andreas H Diacon, Rodney Dawson, Colin Hemez, Rob E Aarnoutse, Pia Abel Zur Wiesch

Get full text

Nontuberculous Mycobacteria in Respiratory Tract Infections, Eastern Asia by Sami Simons, Jakko van Ingen, Po-Ren Hsueh, Nguyen Van Hung, P.N. Richard Dekhuijzen, Martin J. Boeree, Dick van Soolingen

Get full text

Mycobacterium xenopi Clinical Relevance and Determinants, the Netherlands by Jakko van Ingen, Martin J. Boeree, Wiel C.M. de Lange, Wouter Hoefsloot, Saar A. Bendien, Cecile Magis-Escurra, Richard Dekhuijzen, Dick van Soolingen

Get full text

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development by Rami Ayoun Alsoud, Robin J. Svensson, Elin M. Svensson, Elin M. Svensson, Stephen H. Gillespie, Martin J. Boeree, Andreas H. Diacon, Rodney Dawson, Rodney Dawson, Rob E. Aarnoutse, Ulrika S. H. Simonsson

Get full text